Search

everythinglearnresearchcommunity

for

Search:↓

The compounds tested could potentially treat hair loss and alopecia.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Glioblastoma cells can make androgens, which might help the tumor grow.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Some vegetables from Northern Thailand show promise for health benefits, including hair loss treatment and antioxidant properties.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Hair loss in men is common, treatable, but not curable.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Testosterone's muscle-building effects do not require its conversion to DHT.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.